# Neurotropin to Treat Chronic Neuropathic Pain

> **NCT00006289** · PHASE2 · TERMINATED · sponsor: **National Institute of Nursing Research (NINR)** · enrollment: 21 (actual)

## Conditions studied

- Complex Regional Pain Syndrome Type I
- Complex Regional Pain Syndrome Type II

## Interventions

- **DRUG:** Placebo
- **DRUG:** Neurotropin

## Key facts

- **NCT ID:** NCT00006289
- **Lead sponsor:** National Institute of Nursing Research (NINR)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2000-09
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** difficulty in the recruitment of patients
- **Last updated:** 2017-08-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006289, "Neurotropin to Treat Chronic Neuropathic Pain". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00006289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*